Aurobindo Pharma Cipla
Pharma shares in focus: Cipla, Aurobindo Pharma hit 52-week high
Dr Reddy's, Divis Labs, Biocon, JB Chemicals, Caplin Point Lab, Aarti Drugs, Indoco Remedies, RPG Lifesciences and Glenmark Pharma were up in the range of 3% to 5%.
 "Pharma shares in focus: Cipla, Aurobindo Pharma hit 52-week high")
Cipla acquires brand, trademark for anti-diabetic drug Vysov in India
Homegrown pharma major Cipla Ltd on Monday said it has acquired brand name and trademark rights for Vysov for anti-diabetic drug Vildagliptin for the Indian market from Novartis. However, it didn't disclose the acquisition amount. Cipla has been co-marketing Vildagliptin in agreement with Novartis under brand names Vysov and Vysov M (Vildagliptin plus Metformin), the company said in a regulatory filing. "Owing to the increased affordability of Vildagliptin it is more accessible for better management of the disease. Cipla's acquisition of the trademark rights of Vysov will enable us to contribute to easier access of the drug in India," Cipla Executive Vice-President & Head India Business Nikhil Chopra said. The products have witnessed a strong uptake in India for the last couple of years and are currently available across the country, the company said. Vildagliptin is backed by strong clinical data and is therefore a widely prescribed antidiabetic medicine for adults with type-2 ..
 "Cipla acquires brand, trademark for anti-diabetic drug Vysov in India")
Pharma shares in focus; Aurobindo, Cipla, Divis Labs up 4%
At 02:43 pm; Nifty Pharma index, the largest gainer among sectoral indices, was up 2.3% as compared to 0.46% rise in the Nifty 50 index.
 "Pharma shares in focus; Aurobindo, Cipla, Divis Labs up 4%")
